This year’s Crown Award was presented to Dr. Carol and Gene Ludwig to honor their support of the new research building and establishment of The Carol and Gene Ludwig Center for Research on Neurodegeneration. We are glad to be part of this initiative by participating in one of the seed projects with our zebrafish model.
More neurons, less Alzheimer’s: from zebrafish to mammals
A molecular mechanism that zebrafish brain uses to regenerate neurons after neurodegeneration can help us to cope with Alzheimer's, our recent study shows. Induced neurogenesis could be a therapy option for ameliorating Alzheimer's disease pathology. Our recent publication in Nature Partner Journal Regenerative Medicine addresses whether we can use neurogenesis as a means to counteract …
Continue reading "More neurons, less Alzheimer’s: from zebrafish to mammals"
Congratulations for Nature Spin-off Prize Final to Neuron D that commercialized the 3D neural technology developed in our lab!
Find us at the AD/PD 2023 meeting
We will be presenting two posters and will give a talk on our work in zebrafish, mouse and 3D human cultures in ADPD 2023 meeting in Gothenburg.
We will present our work at Karolinska Institute
Title: "Zebrafish as a new functional genomics tool for Alzheimer’s disease" Zebrafish regenerates its brain successfully even in Alzheimer’s disease conditions. No other animal has been shown to do this. The goal of the Kizil lab is to learn from zebrafish how we can enable the human brain to better cope with neurodegenerative disease and …
Continue reading "We will present our work at Karolinska Institute"
Our book chapter is published
Our book chapter on 3D hydrogel cultures and modeling Alzheimer's disease is published in Alzheimer's Disease: Methods and Protocols in Methods in Molecular Biology book series. https://link.springer.com/book/10.1007/978-1-0716-2655-9
Our collaborative publication on a new epitranscriptomic regulation of Tau pathology published
Using cellular and animal models of Alzheimer's disease as well as human brains from clinical cohorts, Santa-Maria Lab's study identified that the RNA-modifying enzyme NOP2/Sun RNA methyltransferase 2 (NSun2) exerted an epitranscriptomic regulation of miR-125b and tau phosphorylation in Alzheimer's disease. This study highlights a novel avenue for therapeutic targeting. We are glad to have …
Kizil Lab moves to Columbia University!
We are happy to announce that we moved to New York to the Department of Neurology and the Taub Institute in Columbia University Irving Medical Center. We are thrilled to continue and expand on our work in zebrafish on Alzheimer’s disease in the great New York City at this great university! Stay tuned!
Our Viewpoint on the use of zebrafish for Alzheimer’s disease is out in ACS Chemical Neuroscience
We are happy to announce our Viewpoint in ACS Chemical Neuroscience on how zebrafish can help us to understand Alzheimer's disease pathology as well as help design new drugs. Zebrafish as an Experimental and Preclinical Model for Alzheimer’s Disease (click to open the publication at the publisher's site in a separate window) Journal cover from …
We discovered new potent multitarget lead compounds for synaptoprotection in Alzheimer’s disease
Happy to announce our publication in Journal of Medicinal Chemistry: Discovery of Potent Cholinesterase Inhibition-Based Multi-Target-Directed Lead Compounds for Synaptoprotection in Alzheimer’s Disease (click to open the link on the publisher's site) Graphical abstract Abstract: Drug development efforts that focused on single targets failed to provide effective treatment for Alzheimer’s disease (AD). Therefore, we designed …
Kizil Lab 